Skip to main content
Fig. 4 | Genome Medicine

Fig. 4

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Fig. 4

The dynamics of serum DNAme markers and CA125 as a function of exposure to Carboplatin-based chemotherapy. The changes in pattern frequency of the three markers as well as CA125 is shown before being compared after two cycles of chemotherapy (ad) in the NACT set. Responder: no recurrence within six months after successful completion of NACT and adjuvant chemotherapy and interval debulking surgery; Non-Responder: either no response to chemotherapy or progression on chemotherapy or recurrence within six months after successful completion of NACT and adjuvant chemotherapy and interval debulking surgery

Back to article page